Avizakimab | Interleukin Related interleukin-related.com

Product Name :
Avizakimab

Search keywords :
Avizakimab

drugId :
null

Target Vo:
Interleukin-21

Target Vo Short Name :
IL21

Moa_Name:
Interleukin-21 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Medimmune

Active Company_Name :
Boston Pharmaceuticals Inc

Active Indication_Name:
Lupus Erythematosus, Systemic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calbindin Rabbit mAb Biological Activity
Calbindin Rabbit mAb Autophagy
Chk1 Antibody (YA505): Chk1 Antibody (YA505) is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to Chk1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts